- Research article
- Open Access
Dopamine presynaptically and heterogeneously modulates nucleus accumbens medium-spiny neuron GABA synapses in vitro
© Geldwert et al; licensee BioMed Central Ltd. 2006
Received: 02 February 2006
Accepted: 30 June 2006
Published: 30 June 2006
The striatal complex is the major target of dopamine action in the CNS. There, medium-spiny GABAergic neurons, which constitute about 95% of the neurons in the area, form a mutually inhibitory synaptic network that is modulated by dopamine. When put in culture, the neurons reestablish this network. In particular, they make autaptic connections that provide access to single, identified medium-spiny to medium-spiny neuron synaptic connections.
We examined medium-spiny neuron autaptic connections in postnatal cultures from the nucleus accumbens, the ventral part of the striatal complex. These connections were subject to presynaptic dopamine modulation. D1-like receptors mediated either inhibition or facilitation, while D2-like receptors predominantly mediated inhibition. Many connections showed both D1 and D2 modulation, consistent with a significant functional colocalization of D1 and D2-like receptors at presynaptic sites. These same connections were subject to GABAA, GABAB, norepinephrine and serotonin modulation, revealing a multiplicity of modulatory autoreceptors and heteroreceptors on individual varicosities. In some instances, autaptic connections had two components that were differentially modulated by dopamine agonists, suggesting that dopamine receptors could be distributed heterogeneously on the presynaptic varicosities making up a single synaptic (i.e. autaptic) connection.
Differential trafficking of dopamine receptors to different presynaptic varicosities could explain the many controversial studies reporting widely varying degrees of dopamine receptor colocalization in medium-spiny neurons, as well as more generally the diversity of dopamine actions in target areas. Longer-term changes in the modulatory actions of dopamine in the striatal complex could be due to plasticity in the presynaptic distribution of dopamine receptors on medium-spiny neuron varicosities.
The synaptic actions of dopamine (DA) in the striatal complex, the principal target of DA neurons in the CNS, may best be described as heterogeneous. In the striatal complex, DA neurons synapse on and in proximity to medium-spiny GABA neurons . Medium-spiny neurons (MSNs) constitute 95% of the neurons in the area [2, 3], receive feed-forward GABAergic inhibition from fast spiking interneurons , and extensive excitatory input from cortex and thalamus, and in the case of MSNs in the ventral striatal complex, or nucleus accumbens (nAcc), also from the amygdala and hippocampus . MSNs give rise to a profusion of local axon collaterals that ramify within the dendritic fields of the parent cell , as well as to all the efferent projections from the striatal complex [7, 8]. Since evoked GABAergic inputs are dominated by the small population of fast-spiking interneurons [4, 9, 10], discerning the function of MSN-to-MSN synapses proved challenging . Recently, dual intracellular recordings in striatal slices  and paired whole-cell recordings both in explant cultures [13, 14] and slices [13, 15–18] have shown that MSN-to-MSN synapses function. Although the synapses appear to be weak, in numbers they account for two thirds of the GABAergic inputs to a given MSN neuron [9, 16], so on a network level their function is likely to be quite significant [11, 16]. The argument can be made that these synapses are a major target of DA action. Indeed, they show potent DA modulation via presynaptic D1-like receptors mediating facilitation and D2-like receptors mediating inhibition .
The cellular and subcellular distribution of DA receptors on individual MSNs – a critical determinant of DA action – has been the subject of considerable debate . Part of the controversy devolves to making the distinction between the molecular biology and the pharmacology. Pharmacologically identified D1-like receptors comprise D1 and D5 receptors; D2-like receptors comprise D2, D3 and D4 receptors . Initial in situ hybridization studies reported the segregation of D1 and D2 receptors to different populations of MSNs [21, 22], and this was amply confirmed in single cell RT-PCR studies , and in expression patterns revealed in D1 and D2 BAC transgenics . D1 receptor expressing MSNs contain SubstanceP and project to the ventral midbrain (the direct pathway) where they show robust D1-mediated presynaptic facilitation [25, 26]. D2 receptor expressing MSNs contain enkephalin and project to the ventral pallidum (the indirect pathway) where they show D2-mediated presynaptic inhibition [27, 28].
While single-cell RT-PCR studies confirmed the lack of D1/D2 receptor colocalization in MSNs, they also showed about a 50% colocalization of D1-like and D2-like receptors . This was confirmed in double-label fluoroprobe studies of MSNs in culture , where receptors were identified pharmacologically. Other studies stand in further counterpoint to these results. In acutely dissociated striatal neurons, biochemical measures of DA modulation indicated near complete D1/D2 overlap . Confocal immunocytochemical studies with D1 and D2 receptor-selective antisera reported near complete D1/D2 colocalization on MSNs identified by DARPP-32 expression . While D1 and D2 receptors are differentially distributed on the two classes of MSNs, accounting for the segregation seen in the in situ studies, expression of the other DA receptors, together with lower levels of receptor expression that may be functionally significant, argue against a strict segregationist view at the functional, i.e. pharmacological level.
The strict segregationist view has been further confounded by single-cell, axon-tracing studies that have shown that there are no direct axonal projections from the striatum to the ventral midbrain. Rather, all MSNs project to the pallidum, with about a third terminating there, and the remaining two thirds going on to the entopeduncular nucleus and the ventral midbrain [32, 33]. This anatomy is consistent with physiological studies, in which MSN-to-MSN connections were activated by antidromic activation from the ventral pallidum. This showed that Substance P-containing neurons are subject to D1 modulation at their projection synapses and D2 modulation at their local synapses (in the striatum), while enkephalin-containing neurons are subject to D2 modulation at their projection synapses and D1 modulation at their local synapses .
While the consensus is that there is about a 50% overlap in D1- and D2-like DA receptor expression at the cell body level, the projection synapses of MSNs show either D1 or D2 pharmacology. Surmeier et al. , in a prescient review, suggested the possibility that DA receptors might be trafficked differentially into the axons of individual MSNs, accounting for the differences seen between local DA actions reported in the striatum (both pre- and postsynaptic) and distal actions on MSN projection synapses. To examine DA modulation of individual MSN-to-MSN synapses, and to address the hypothesis that DA receptors show differential trafficking, we used postnatal cell culture to gain access to individual, identified MSN synapses. We have found that there is significant presynaptic DA modulation. Moreover it is heterogeneous, consistent with differential trafficking of DA receptors to different presynaptic varicosities in single neurons. Part of this work has appeared previously in abstract form [34–36].
GABAergic connections of medium-spiny neurons in vitro
In postnatal cultures made from the nucleus accumbens, the ventral component of the striatal complex, 95% of the neurons are medium-sized, GABAergic , and bear dendritic spines , serving to identify them as the predominant MSN population. The GABAA antagonists Bicuculline (50 μM) or Gabazine (SR-95531, 10 μM)  invariably inhibited the synaptic actions of these neurons, confirming their identification as MSNs. We present data from 82 MSNs (of a total of 166 recorded), in which cells remained healthy throughout the experiment, with small, stable leak currents, and in which there was satisfactory drug perfusion (IPSCs inhibited to <5% with GABAA blockade at the beginning and end of experiments). Input resistances measured 503 ± 36 MΩ (mean ± s.e.m.).
DA modulation of autaptic connections. Data are organized by the receptor targeted. The Incidence data give the percent of connections that showed modulation greater than 5%; less that a 5% modulation is reported as Neither. The Magnitude data (expressed as the percentage of the preceding control response) give the average size of the inhibited or facilitated IPSC for those connections showing inhibition or facilitation, respectively. DA or the combination of the D1 agonist SKF38393 (SKF) and the D2 agonist quinpirole (Quin) targeted DA receptors as a class. SKF38393 or DA in the presences of Sulpiride (Sulp) targeted D1 receptors. Similarly, Quinpirole or DA in the presence of the D1 antagonist SCH23390 (SCH) targeted D2 receptors. The other monoamines norepinephrine (NE) and serotonin (5-HT) were also tested. n/a, not applicable.
SKF & Quin
DA & Sulp
DA & SCH
Tests for pharmacological specificity were confounded by the fact that the antagonists at higher concentrations inhibited autaptic responses. To obtain larger and more stable responses for these experiments, we used a high-chloride intracellular solution, which flipped the IPSCs, but did not appreciably alter the DA modulation. We found that SCH23390 at 50 μM produced a complete blockade (n = 3), probably due to a direct inhibition of Ca2+ currents . SCH23390 at 0.1 to 1.0 μM had a slight (<10%) inhibitory effect on autaptic responses, but completely blocked DA actions (n = 7). Similarly, the D2 antagonist Sulpiride inhibited (but did not block) autaptic responses at 50 μM; at 10 μM it had only a modest or no effect on autaptic responses (n = 6). Applied together (Figure 3A), however, these concentrations of SCH23390 and Sulpiride completely blocked DA modulation of autaptic responses (n = 6 of 6), arguing that the modulatory effects were mediated by DA receptors. DA in the presence of the D1 receptor antagonist SCH23390 had a similar incidence and efficacy as Quinpirole (n = 10); similarly, DA in the presence of the D2 antagonist Sulpiride (1 μM) resembled SKF38393 (n = 10). Overall, about 85% of cells that responded to DA showed both D1- and D2-mediated modulation, consistent with extensive colocalization of DA receptors on MSN presynaptic varicosities, or at least arguing that D1- and D2-like receptors are both present on the varicosities of single neurons (see below).
We showed previously that the GABAB agonist Baclofen (100 μM) produced robust presynaptic inhibition, blocking autaptic responses . Autaptic responses were inhibited by the other monoamines norepinephrine (10 μM) or serotonin (2 μM). These modulatory actions were apparently independent of DA receptors, as there were instances (n = 2) where the autaptic response was sensitive to the other transmitters but insensitive to DA (Figure 3B). So, a single synaptic connection may be subject to modulation via a multiplicity of presynaptic receptors – both autoreceptors and heteroreceptors.
Modulation is presynaptic
DA receptor visualization by immunostaining
DA differentially modulates two-component nAcc autaptic connections
DA differentially modulated the different autaptic components (Figure 7A). In the majority of the experiments DA modulation of Comp1 was the largest, but in no experiment was the modulation or the multiple components the same. The effects of selective agonists were tested successfully in experiment number 5 (Figure 7B). Exponential extrapolation of the decay of Comp1 and subtraction to isolate Comp2 (labeled 2') revealed that DA markedly attenuated Comp1, with little effect on Comp2' (Figure 7B1). In contrast, the D1 agonist SKF38393 facilitated Comp1 with no effect on Comp2' (Figure 7B2). The D2 agonist Quinpirole significantly attenuated Comp1 while modestly facilitating Comp2' (Figure 7B3). Since the two components must be regarded as being part of a single synaptic connection – just separated temporally by the conduction time due to an intervening length of axon – DA is apparently able to modulate release sites making up a single synaptic connection differentially.
In experiment 5, in which there was the greatest temporal separation of the components, we were able to compare the decay of the control responses and their rise time. As plotted in Figure 2B, Comp1 decayed over about 10 min to a relative plateau at about 25% of the initial value, presumably due to washout; in contrast, Comp2 was stable throughout most of the experiment (just over an hour), presumably because the intervening axonal segment retarded washout. The rise time of Comp1, 1.07 msec, was slightly faster than that of Comp2', 1.47 msec. The smaller amplitude and slower rise time of Comp2 would be expected if it was mediated by synaptic varicosities that impinged on more distal dendrites than those that mediated Comp1.
In postnatal nAcc cultures, we examined MSN-to-MSN synaptic connections and their modulation by DA. We focused on autaptic responses because they provided access to single, identified synaptic connections. Autaptic responses were subject to presynaptic DA modulation, with D2-like receptors predominantly mediating inhibition, and D1-like receptors more often mediating facilitation. The majority of connections showed both D1 and D2 modulation, consistent with significant receptor co-expression. In some cells, the autaptic responses had two or three components that were differentially modulated by DA, consistent with differential trafficking of DA receptors to different presynaptic varicosities of the same cell.
Medium-spiny neuron connections in vitro
In postnatal culture, most MSN neurons show a single autaptic GABAA mediated, Ca2+-dependent after-hyperpolarization . Some connections had a delayed component, with fixed latency, that we would argue was a second autaptic connection made after the MSN axon had traveled for some distance, introducing a conduction delay. MSN autapses have not been reported in the intact circuitry of the brain, and so they presumably arise in culture because of the artificial conditions, which include the immaturity of the cells, the lack of afferentation, the lack of normal projection targets, and the two-dimensionality of the cultures, any or all of which presumably contribute to the propensity of the cells to form autaptic connections. That being stated, MSN autapses do provide a powerful window on the synaptic capabilities of the cells, and serve to frame hypotheses that may be tested in the intact circuitry of the striatal complex, which we have now done .
Stimulating adjacent MSNs evoked a synaptic response of larger amplitude and faster rise time that was resistant to washout. Synaptic connections might impinge on more proximal somatodendritic membranes, consistent with recent observations suggesting that different populations of GABAergic inputs can be differentially distributed over the dendritic arbor . The stability of the synaptic response confirmed that postsynaptic GABAA receptor sensitivity was maintained with the standard intracellular solution we used . The single autaptic response, or the first component of the multicomponent autaptic response, showed a progressive decrease in amplitude over the course of about 15 min, which would be expected if the release sites mediating the response were close to the recording electrode in the cell soma and so subject to washout. The second component of the multicomponent autaptic response was typically smaller in amplitude and slower in rise time arguing that the recurrent axon made a more distal and thus weaker autaptic connection. Consistent with this, the second component was resistant to washout, presumably due to the functional diffusion limitation of the more distal axon. Interestingly, while the single autaptic component decreased to a fraction of its initial amplitude, the magnitude of DA modulation did not decrease.
The argument could be made that the single autaptic response – or the first component of the multicomponent response – was mediated by an autoreceptor current mechanism, as described by Pouzat and Marty in cerebellar interneurons . Indeed, we observed strikingly similar washout kinetics. However, washout of key elements of the presynaptic machinery does not distinguish between an autoreceptor current (where the presynaptic varicosity is also the postsynaptic element) and an autaptic (axodendritic) response, but amplitude does. A comparison of the flipped IPSC elicited with similar high chloride-intracellular solutions used revealed that the autaptic responses we recorded were an order of magnitude larger. Given the two-dimensional neuropil of the cultures, which should limit the numbers of proximal presynaptic varicosities, we should have obtained the opposite result. A further comparison with their data revealed that second autaptic component they measured, which they deemed to be axodendritic, was in fact larger, rather than smaller, as we observed. The lack of evidence for GABAA receptors at presynaptic sites, either in the intact striatum  or in nAcc culture , argues further against the autoreceptor current mechanism. In our FM1-43 experiments, field stimulation that activated most synapses in the culture did not evoke sufficient GABA release to activate presynaptic GABAB receptors and arrest destaining. So there would not have been sufficient GABA release to activate presynaptic GABAA receptors, even if they were present, arguing further against the autoreceptor current mechanism. Therefore, the autaptic responses reported here, and in our previous study , are mediated by bone fide axodendritic autaptic connections.
DA was the most effective DA agonist, producing on average about a 50% inhibition of autaptic responses. In rare experiments, DA produced near complete inhibition. However, DA was not as robust as the GABAB agonist Baclofen, which consistently shut down the autapses . DA and a combination of D1 and D2 agonists produced a similar incidence of modulation, but equimolar DA concentrations produced more robust inhibition (but not facilitation). Receptor family-selective modulation with DA and a single antagonist was also more robust that the corresponding single agonist. This was not due to DA acting via other monoaminergic receptors [viz. ], as there were clear instances where norepinephrine and serotonin modulated MSN synaptic connections that showed modest DA modulation. Moreover, the magnitude of the monoamine inhibition was no greater than the magnitude of DA inhibition, so it would be unlikely that DA, a poor serotonin or noradrenergic agonist, would have that much effect via the heterologous receptors. More likely, DA and the selective agonists activated different DA receptor confirmations with differing potencies, as has been described for both D1 and D2 receptors [58–61].
Most MSN connections showed both D1 and D2 modulation, consistent with near complete overlap in the expression of D1- and D2-like receptors on individual MSNs. Reports of a lesser incidence of colocalization (summarized in the Background) may be ascribed in part to detection issues with the different methodologies employed. It may be argued that physiological data, reflecting the actual function of the receptors, provide the most sensitive validation [31, 62]. The apparent contradictions in the results could also be explained by differential trafficking of DA receptors (see below).
Presynaptic DA modulation
Slice studies indicate that most DA modulation of MSNs arises through modulation of synaptic inputs onto the cells with only a minor postsynaptic contribution . DA depresses GABAA responses via postsynaptic action, but the magnitude was on the order of 20% , whereas we observed a modulation on the order of 50%, arguing for an additional presynaptic action. Guzman et al.  provided the first evidence for presynaptic DA modulation in the striatal slice. Our paired-pulse experiments provide evidence for presynaptic modulation of MSN-to-MSN connections in culture. Direct imaging of DA modulation via inhibition of FM1-43 destaining showed that both D1 and D2 agonists arrested destaining. Although we cannot be certain that the varicosities we imaged all belonged to MSNs, the sheer numbers argue that we were. Moreover, MSNs show presynaptic modulation of their projection synapses [25, 28], so the neurons are clearly capable of mounting presynaptic DA receptors.
Presynaptic actions of DA in the striatal complex have been called into question by the dearth of morphological evidence for presynaptic DA receptors [47, 65–70]. However, there is extensive physiological evidence for presynaptic DA receptors on three classes of synapses in the striatal complex. Presynaptic D2 autoreceptors on DA neuron terminals inhibit DA release , D2 heteroreceptors on corticostriatal terminals inhibit glutamatergic inputs , and presynaptic D1 and D2 heteroreceptors on MSN terminals modulate GABAergic IPSCs [present results, and Refs. [9, 73]]. DA receptors can be visualized using fluoroprobe antagonists on FM1-43 labeled presynaptic varicosities of both nAcc and striatal MSNs in postnatal culture . When exogenous DA receptors tagged with yellow fluorescent protein (EYFP) are chemically transfected into nAcc cultures, they take up presynaptic positions . Antipeptide antisera directed against D1 and D2 receptor epitopes mainly visualize receptors on axonal segments and presynaptic varicosities, cell bodies, but not dendrites. Possibly, presynaptic receptors are more easily solubilized [viz. Ref. ] with the usual concentrations of detergent used in preparing tissue for immunostaining, and so could account for an artifactual underestimate of the incidence of presynaptic DA receptors. Indeed, we have found that eliminating detergent from the immunostaining protocol dramatically enhanced presynaptic immnolabeling. In culture, the use of detergent is unnecessary presumably because the fixation process adequately permeabilizes cells. Consistent with this supposition, we obtained similar staining patterns using antipeptide antisera directed to extracellular and to intracellular epitopes (in the absence of detergent).
Presynaptic modulation is heterogeneous
As suggested by Surmeier et al. , much of the controversy regarding the distribution of DA receptors on MSNs in the striatal complex would be resolved if MSNs traffic DA receptors to their presynaptic varicosities differentially. Otherwise it is difficult to integrate anatomical studies indicating that MSNs project sequentially rather than in parallel to their major target areas [32, 33], with physiological studies showing D2 inhibition of MSN projections to pallidal neurons  and D1 facilitation on projections to the ventral midbrain , and data showing extensive co-expression of D1 and D2-like receptors in MSNs [29, 31, 62].
To show differential trafficking directly requires studies at the level of single cells. We have fortuitously found that some MSNs in postnatal culture show multicomponent autaptic responses. Since both responses share the same presynaptic and postsynaptic elements, they should be considered to be components of the same synaptic connection. And, given that they are connections between MSNs, they then represent the majority of intrinsic synapses in the striatal complex. We cannot rule out the possibility that the autaptic connections arise aberrantly in the absence of their projection targets, given the lack of documented autaptic connections in the intact circuitry. However, this does not detract from the fact that we have access to two separate populations of presynaptic varicosities that together make up a single MSN synaptic connection.
Given this fortuitous situation, we were able, in the experiments with two-component autaptic responses, to test the differential effect of DA agonists. If DA receptors were distributed homogeneously on all the presynaptic receptors of a given MSN, we would expect that both components of the autaptic response should show the same modulation. If the magnitude of the modulation differed, one could argue that the distribution was relatively homogenous, with variation in the level of expression at different varicosities. However, we found that D1 or D2 modulation might be lacking on one connection or have opposite effects, consistent with true differential trafficking of the receptors. The discrepancy between our FM1-43 experiments, which showed that varicosities were inhibited on an all-or-none basis, and the electrophysiology, which showed about a 50% inhibition, argues that a mix of unaffected and strongly modulated presynaptic varicosities accounts for the modulation we observed electrophysiologically. The immunocytochemical results that showed D1 or D2 receptors on only a subset of MSN varicosities argue against differential coupling to postreceptor mechanisms and for differential trafficking. In recent nAcc slice studies, we have shown that DA modulates Ca2+ influx into the varicosities of single MSNs heterogeneously, providing further evidence for differential trafficking .
Our present culture results, building on several lines of evidence and supported by recent slice studies, make the strong argument that individual MSNs differentially traffic DA receptors to their presynaptic varicosities. Definitive support for this argument will require imaging the distribution of DA receptors in single MSNs directly. We cannot exclude the possibility that the presence of aberrant projection synapses in the intrinsic population in our cultures accounts for the differential distribution of DA receptors we have observed. Gaining insight into the distribution of DA receptors on the local synapses of individual MSNs holds considerable import. DA is arguably the major modulator of information processing in the area. If DA receptors are differentially trafficked to MSN intrinsic synapses, and moreover if trafficking is plastic, then the distribution of presynaptic receptors would play a crucial role in the dynamic regulation of information processing in the striatal complex.
Dopamine, DA agonists and antagonists, as well as Gabazine (SR-95531; 2-(3-Carboxypropyl)-3-amino-6-(4 methoxyphenyl)pyridazinium bromide) were obtained from Sigma-Aldrich. We used Gabazine to avoid the confound that bicuculline salts block S-K+ channels via a tetraethylammonium (quaternary ammonium group) like effect . CNQX and CGP35348 were from Tocris-Cookson. FM1-43 was from Molecular Probes/InVitrogen. DA and all drugs used were made up in 1000× stock solutions, stored frozen at -80°C in aliquots, and thawed immediately before use. In initial experiments, ascorbic acid was included in the DA stock solution (at 10× the DA concentration) to prevent DA oxidation; however, this had no appreciable benefit, so the DA application experiments with and without ascorbic acid were pooled.
Postnatal neuronal culture
We cultured neurons from the nucleus accumbens (nAcc) of postnatal (P2) Sprague-Dawley rat pups (Hilltop Lab Animals), with only minor modifications from our previously published methods [29, 38]. Animal procedures were approved by the Institutional Animal Care and Use Committees of Columbia University and the New York State Psychiatric Institute, and were in compliance with the USPHS Guide for the Care and Use of Laboratory Animals. Pups were anesthetized with ketamine/xylazine, then chilled in ice chips, and decapitated. Brains were removed into chilled phosphate-buffered saline. An astrocyte feeder layer was prepared from the dorsal cortex two weeks in advance of making neuron cultures. For this, enzymatically-dissociated cortical cells were plated in the ~100 μL wells of glass-bottom dishes (MatTek) that had been coated with laminin; after 1 hour, wells were vigorously washed with cold medium leaving only strongly adherent astrocytes; once these grew to near confluence, further division was halted with fluorodeoxyuridine.
To obtain nAcc neurons, we cut the front half of the brain sagitally along the midline and made a 2 mm thick horizontal slice centered on the anterior commissure; further cuts were made using the ventral tip of the lateral ventricle as the medial cut to isolate the nAcc in a 2 × 2 × 2 mm cube. This was cut further into 1 × 1 × 1 mm segments and incubated in Papain (Worthington) at 32°C with gentle agitation and continuous carbogenation. After 90 min, the Papain was quenched with medium containing 10% calf serum and the tissue cubes dissociated to single cells by three rounds of gentle trituration in the presence of DNAase. Neurons were resuspended in B-27 supplemented NeurobasalA medium (Invitrogen), with 1% heat-inactivated supplemented-defined calf serum (Hyclone), added to assure glial longevity, and plated onto the pre-established monolayers of cortical astrocytes (in the microwells). Cultures were maintained in a total volume of 2.5 ml (which filled the whole dish), and never fed. To prevent microglial proliferation, fluorodeoxyuridine was added again after 7 days in vitro (DIV). Experiments were conducted on cultures between 10 and 21DIV, a period during which numbers of synapses are relatively stable .
Recordings were done at room temperature (~22°C) on the stage of an inverted microscope (Zeiss IM35 or Axiovert35M). The culture medium was replaced with oxygenated extracellular solution containing 135 mM NaCl, 3 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM glucose and 10 mM N-(2-Hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) (HEPES), pH7.35 (with KOH). Patch pipets, 6-9MΩ, were pulled on a P-80/PC Flaming-Brown Micropipet Puller (Sutter), and filled with either a standard intracellular solution that contained 140 mM gluconic acid, 140 mM KOH, 0.1 mM CaCl2, 2 mM MgCl2, 1 mM ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), 2 mM ATP, 0.1GTP and 10 mM HEPES, pH7.25, or a high-chloride solution – transforming IPSCs into larger EPSCs – that contained 130 mM KCl, 0.1 mM CaCl2, 4.6 mM MgCl2, 10 mM HEPES, 1 mM EGTA, 4 mM ATP and 0.4 mM GTP, pH7.25.
Experiments were controlled by a Power Macintosh (Apple Computer) using IgorPro (Wavemetrics) with PulseControl XOP's . Neurons were voltage clamped to -60 mV (to resolve autaptic currents and to prevent repetitive firing) using an Axoclamp2A (in continuous single electrode voltage clamp mode) or an Axopatch 200 (Axon Instruments/Molecular Devices). This holding potential did not include a correction for the liquid junction potential of about -15 mV, so the actual holding potential was about -75 mV. Membrane currents were digitized (Instrutech ITC-16 interface) and recorded (PulseControl) to disk. Compensation for passive conductance and series resistance was done by adding a scaled average of four -5 mV pulses delivered after each epoch of data acquisition (PulseControl: Subtraction Pulses Global). Further analysis of the data was done in IgorPro or Axograph (Axon Instruments/Molecular Devices).
Drugs were applied by local perfusion via a solenoid-controlled, gravity-fed Y-tube system; multiple drug-application channels were available via a rotary fluid switch (Rainin). Following solenoid activation, onset of drug perfusion was rapid, but delayed by about 5 sec, which was required for reversal of flow through the drug application tube. When the solenoid was deactivated, drug was rapidly removed by reverse flow through the drug-application tube. Fast green was used in some experiments to verify proper performance of the local perfusion system; it had no apparent pharmacologic effects at the concentration used. Drug effects were deemed significant if they exceeded 5%. To assure that drug application was uniform over the recorded cell, all experiments began with the application of bicuculline or gabazine, and were not continued unless better than 95% GABA blockade was obtained; as possible, experiments were also concluded with a test of GABA blockade, and if the blockade was not 95% or better, the experiments were discarded.
Unclamped A-spikes were evoked with 1 msec step depolarizations of about 30 mV to elicit autaptic currents. Voltage clamp control was such that we were often able to reestablish a brief zero-current epoch before the autaptic response. Synaptic responses were evoked by 1 msec depolarizing pulses delivered to the adjacent neuropil or cell bodies via a loose patch electrode; in some cases, the recorded cell was backfired, as was evident by an evoked action current spike; these responses were deemed autaptic, as they differed in no appreciable way from responses evoked by somatic depolarizing pulses. In contrast, synaptic responses showed no preceding inward current spike and rose cleanly from the baseline with a sharp inflection.
In most experiments, cells were stimulated at 0.1 Hz. Latencies of synaptic responses were measured from the peak of the action current, or from the stimulus artifact if its peak merged with the action current, to the point of maximum inflection at the onset of the synaptic response. Rise times were measured as the time from 10 to 90% of the peak amplitude of the synaptic current (AxoGraph). Five control responses were considered, then drugs was applied by local perfusion. After about 30 sec, which were required for responses to stabilize, five drug responses were then averaged, and the drug washed off. Again, after about 60 sec, when responses had again stabilized, five responses were averaged for a post-drug control. Numerical data were expressed as mean ± s.e.m. Significance of differences was evaluated by t-test.
In two-component responses, the second component, Comp2' was isolated by exponential curve fitting and subtraction. The assumption was made that the late decay (40 – 100 msec) of Comp2 would be representative of the decay of the first component, Comp1; indeed, in single component responses, the decay was well fit by a single exponential (IgorPro),
This late exponential curve fit was scaled to the amplitude of the first component (A set to ratio of the amplitudes of Comp1/Comp2) and shifted temporally by the interval (Δt) between the components (t0 set to t0-Δt). This provided an extrapolation of the decay of Comp1 uncontaminated by Comp2, which was then subtracted from the raw trace to yield a pure second component, Comp2'. In the experiments considered, Comp2' decayed properly to the baseline.
Cultures were processed to visualize DA receptors following standard immunocytochemistry protocols. Briefly, cultures were slow fixed with 4%formaldehyde (prepared from 8% paraformaldehyde, EM Sciences, and 2× phosphate buffer) + 0.3% glutaraldehyde (Sigma-Aldrich). Polyclonal antipeptide antisera to D1a and D2 receptors (Marjorie A. Ariano, Rosalind Franklin University of Medicine and Science; Chemicon) were applied at 1:1000 dilution, overnight at 4°C, and then visualized using fluorescent secondary antisera (Chemicon). Detergent was not used. Sequences of images were acquired (Zeiss Axiovert; Scanalytics IP-Lab), at 0.5 μm intervals (Ludl Z-motor) using a Sensys chilled-CCD camera (Photometrics/Roper Scientific), and digitally deconvolved to produce confocal images (VayTek Microtome). The sequence of images encompassing the varicosities of interest were Z-projected and overlaid on the corresponding Nomarski-DIC images (Fluorescence CV, IP-Lab extension).
Activity-dependent FM1-43 destaining
Synapses were loaded with FM1-43 (10 μM) by field stimulation (20 V applied between platinum electrodes, placed 1 cm apart on either side of the microwell) with a train of 1 msec duration pulses delivered at 20 Hz for 30 sec. After 5 min to allow for endocytosis, the FM1-43 was removed with three washes. The same imaging system as described above was used to image FM1-43 destaining, with the addition of a MacLab/8 (Analog Digital Instruments) for automation. The MacLab was programmed to deliver timed TTL pulses to trigger the camera, fluorescence shutter, stimulator, and the drug-application solenoid valve; pulse sequences were recorded (MacLab Chart software) to produce a graphical log. Images were acquired every 1.25 sec (200 msec exposure; camera gain on high), and after a control period, destaining was initiated by slow stimulation at 4 Hz. During this stimulation, drugs were applied by local perfusion for a discrete time interval; presynaptic inhibition would be expected to slow or arrest destaining, while facilitation would be expected to accelerate destaining. Stimulation was continued after drug application to confirm that destaining resumed. Stimulation was then stopped, and after images were acquired to establish the new baseline, a second tetanus (20 Hz for 20 sec) was delivered to unload remaining FM1-43 and confirm that activity-dependent destaining was not exhausted to rule out a floor effect. Experiments were only analyzed if they met the following criteria: a stable plateau prior to stimulation, destaining with the onset of stimulation, a stable post-stimulation baseline, and a final tetanus-induced destaining. In some experiments, to test whether stimulated GABA release might reduce the efficacy of stimulation for loading or destaining via presynaptic inhibition, the GABAB antagonist CGP35348 (500 μM) was included throughout; however, this made no appreciable difference, so experiments with and without CGP35348 were pooled in the data tabulation.
For analysis, 10 regions of interest (ROI's) 2 μm square were selected – nine ROI's were of individual varicosities that were easily resolved from adjacent varicosities, and one ROI of an area containing no varicosities for determination of background staining. The intensity of the background ROI was subtracted from the other intensity measurements at each time point. Intensities were normalized to the average intensity of the initial control frames. There were occasional fluctuations in the intensity of the mercury arc, which were reflected by simultaneous jumps in the intensity in all 10ROI's; these points were removed and the average of the two adjacent time points used instead. Finally, traces were smoothed using a fifth power Gaussian algorithm (IgorPro).
We used a Monte Carlo simulation to evaluate the significance of the destaining results. An ideal no-effect curve was generated and scaled noise added to reproduce the appearance of the actual data. We then scored four series of 250 simulations to determine how often this noise level produced an apparent effect. We applied the same criteria used for the actual data, namely a readily evident slowing of destaining shortly after the onset of drug application and a resumption of destaining after drug application was stopped. In the four simulations, we observed an effect in 0.9 ± 0.3% of the traces, making p < 0.01 that the results we observed arose by chance.
We thank Wei-Xing Shi for preliminary experiments, Marjorie A. Ariano for DA receptor antisera, Ling Lin for cell culture preparation, and Takeo Mizuno for critical discussion. Supported by NIDA (DA000356, DA008675) and the Burroughs Wellcome Fund.
- Pickel VM, Nirenberg MJ, Milner TA: Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporters and receptors. Journal of Neurocytology. 1996, 25 (12): 843-856. 10.1007/BF02284846.View ArticlePubMedGoogle Scholar
- Smith AD, Bolam JP: The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends in Neurosciences. 1990, 13: 259-265. 10.1016/0166-2236(90)90106-K.View ArticlePubMedGoogle Scholar
- Pennartz CM, Groenewegen HJ, Lopes da Silva FH: The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Progress in Neurobiology. 1994, 42 (6): 719-761. 10.1016/0301-0082(94)90025-6.View ArticlePubMedGoogle Scholar
- Koos T, Tepper JM: Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nature Neuroscience. 1999, 2 (5): 467-472. 10.1038/8138.View ArticlePubMedGoogle Scholar
- Wilson CJ: Basal ganglia. The Synaptic Organization of the Brain. Edited by: Shepherd GM. 2004, New York , Oxford University Press, 361-413. FifthView ArticleGoogle Scholar
- Kawaguchi Y, Wilson CJ, Emson PC: Projections subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. Journal of Neuroscience. 1990, 10: 3421-3438.PubMedGoogle Scholar
- Wilson CJ, Groves PM: Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase. Journal of Comparative Neurology. 1980, 194 (3): 599-615. 10.1002/cne.901940308.View ArticlePubMedGoogle Scholar
- Smith Y, Bevan MD, Shink E, Bolam JP: Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience. 1998, 86 (2): 353-387. 10.1016/S0306-4522(98)00004-9.View ArticlePubMedGoogle Scholar
- Guzman JN, Hernandez A, Galarraga E, Tapia D, Laville A, Vergara R, Aceves J, Bargas J: Dopaminergic modulation of axon collaterals interconnecting spiny neurons of the rat striatum. J Neurosci. 2003, 23 (26): 8931-8940.PubMedGoogle Scholar
- Tecuapetla F, Carrillo-Reid L, Guzman JN, Galarraga E, Bargas J: Different inhibitory inputs onto neostriatal projection neurons as revealed by field stimulation. J Neurophysiol. 2005, 93 (2): 1119-1126. 10.1152/jn.00657.2004.View ArticlePubMedGoogle Scholar
- Plenz D: When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function. Trends Neurosci. 2003, 26 (8): 436-443. 10.1016/S0166-2236(03)00196-6.View ArticlePubMedGoogle Scholar
- Tunstall MJ, Oorschot DE, Kean A, Wickens JR: Inhibitory interactions between spiny projection neurons in the rat striatum. J Neurophysiol. 2002, 88 (3): 1263-1269.PubMedGoogle Scholar
- Czubayko U, Plenz D: Fast synaptic transmission between striatal spiny projection neurons. Proc Natl Acad Sci U S A. 2002, 99 (24): 15764-15769. 10.1073/pnas.242428599.PubMed CentralView ArticlePubMedGoogle Scholar
- Gustafson N, Gireesh-Dharmaraj E, Czubayko U, Blackwell KT, Plenz D: A comparative voltage and current-clamp analysis of feedback and feedforward synaptic transmission in the striatal microcircuit in vitro. J Neurophysiol. 2006, 95 (2): 737-752. 10.1152/jn.00802.2005.View ArticlePubMedGoogle Scholar
- Taverna S, van Dongen YC, Groenewegen HJ, Pennartz CMA: Direct physiological evidence for synaptic connectivity between medium-sized spiny neurons in rat nucleus accumbens in situ. J Neurophysiol. 2004, 91 (3): 1111-1121. 10.1152/jn.00892.2003.View ArticlePubMedGoogle Scholar
- Koos T, Tepper JM, Wilson CJ: Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. J Neurosci. 2004, 24 (36): 7916-7922. 10.1523/JNEUROSCI.2163-04.2004.View ArticlePubMedGoogle Scholar
- Venance L, Glowinski J, Giaume C: Electrical and chemical transmission between striatal GABAergic output neurones in rat brain slices. J Physiol. 2004, 559 (Pt 1): 215-230. 10.1113/jphysiol.2004.065672.PubMed CentralView ArticlePubMedGoogle Scholar
- Taverna S, Canciani B, Pennartz CM: Dopamine D1-receptors modulate lateral inhibition between principal cells of the nucleus accumbens. J Neurophysiol. 2005, 93 (3): 1816-1819. 10.1152/jn.00672.2004.View ArticlePubMedGoogle Scholar
- Surmeier DJ, Reiner A, Levine MS, Ariano MA: Are neostriatal dopamine receptors co-localized?. Trends in Neurosciences. 1993, 16 (8): 299-305. 10.1016/0166-2236(93)90103-S.View ArticlePubMedGoogle Scholar
- Neve KA, Neve RL: Molecular biology of dopamine receptors. The Dopamine Receptors. Edited by: Neve KA, Neve RL. 1997, Totowa, NJ , Humana Press, 27-76.View ArticleGoogle Scholar
- Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR: D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990, 250: 1429-1432.View ArticlePubMedGoogle Scholar
- Le Moine C, Bloch B: D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. Journal of Comparative Neurology. 1995, 355 (3): 418-426. 10.1002/cne.903550308.View ArticlePubMedGoogle Scholar
- Surmeier DJ, Song WJ, Yan Z: Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Journal of Neuroscience. 1996, 16 (20): 6579-6591.PubMedGoogle Scholar
- Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner A, Leblanc G, Hatten ME, Heintz N: A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 2003, 425 (6961): 917-925. 10.1038/nature02033.View ArticlePubMedGoogle Scholar
- Cameron DL, Williams JT: Dopamine D1 receptors facilitate transmitter release. Nature. 1993, 366: 344-347. 10.1038/366344a0.View ArticlePubMedGoogle Scholar
- Radnikow G, Misgeld U: Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. Journal of Neuroscience. 1998, 18 (6): 2009-2016.PubMedGoogle Scholar
- Mengual E, Pickel VM: Ultrastructural immunocytochemical localization of the dopamine D2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Synapse. 2002, 43: 151–162-10.1002/syn.10033.View ArticlePubMedGoogle Scholar
- Cooper AJ, Stanford IM: Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro. Neuropharmacology. 2001, 41: 62–71-10.1016/S0028-3908(01)00038-7.View ArticlePubMedGoogle Scholar
- Wong AC, Shetreat ME, Clarke JO, Rayport S: D1- and D2-like dopamine receptors are colocalized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro. Neuroscience. 1999, 89 (1): 221-233. 10.1016/S0306-4522(98)00284-X.View ArticlePubMedGoogle Scholar
- Bertorello AM, Hopfield JF, Aperia A, Greengard P: Inhibition by dopamine of (Na++K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature. 1990, 347 (6291): 386-388. 10.1038/347386a0.View ArticlePubMedGoogle Scholar
- Aizman O, Brismar H, Uhlén P, Zettergren E, Levey AI, Forssberg H, Greengard P, Aperia A: Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nature Neuroscience. 2000, 3 (3): 226-230. 10.1038/72929.View ArticlePubMedGoogle Scholar
- Wu Y, Richard S, Parent A: The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neuroscience Research. 2000, 38 (1): 49-62. 10.1016/S0168-0102(00)00140-1.View ArticlePubMedGoogle Scholar
- Parent A, Sato F, Wu Y, Gauthier J, Levesque M, Parent M: Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci. 2000, 23 (10 Suppl): S20-7. 10.1016/S1471-1931(00)00022-7.View ArticlePubMedGoogle Scholar
- Geldwert D, Rayport S: Dopaminergic modulation of nucleus accumbens GABA synapses. Society for Neuroscience Abstracts. 1996, 22: 506.Google Scholar
- Feldman IG, Rayport S: Dopamine presynaptically inhibits n. accumbens GABA synapses via D1- and D2-like receptors: Visualization by FM1-43 destaining in postnatal cell culture. Society for Neuroscience Abstracts. 1998, 24: 349.Google Scholar
- Rayport S, Geldwert D, Norris J: Dopamine differentially modulates medium-spiny GABA neuron synapses. Soc Neurosci Abstr. 2001, 27.Google Scholar
- Shetreat ME, Lin L, Wong AC, Rayport S: Visualization of D1 dopamine receptors on living nucleus accumbens neurons and their colocalization with D2 receptors. Journal of Neurochemistry. 1996, 66 (4): 1475-1482.View ArticlePubMedGoogle Scholar
- Shi WX, Rayport S: GABA synapses formed in vitro by local axon collaterals of nucleus accumbens neurons. Journal of Neuroscience. 1994, 14 (7): 4548-4560.PubMedGoogle Scholar
- Ueno S, Bracamontes J, Zorumski C, Weiss DS, Steinbach JH: Bicuculline and gabazine are allosteric inhibitors of channel opening of the GABAA receptor. J Neurosci. 1997, 17 (2): 625-634.PubMedGoogle Scholar
- Guenther E, Wilsch V, Zrenner E: Inhibitory action of haloperidol, spiperone and SCH23390 on calcium currents in rat retinal ganglion cells. Neuroreport. 1994, 5 (11): 1373-1376.PubMedGoogle Scholar
- Davies CH, Davies SN, Collingridge GL: Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. J Physiol (Lond). 1990, 424: 513-531.View ArticleGoogle Scholar
- Wilcox KS, Dichter MA: Paired pulse depression in cultured hippocampal neurons is due to a presynaptic mechanism independent of GABAB autoreceptor activation. Journal of Neuroscience. 1994, 14 (3 PT 2): 1775-1788.PubMedGoogle Scholar
- Betz WJ, Mao F, Smith CB: Imaging exocytosis and endocytosis. Current Opinion in Neurobiology. 1996, 6: 365-371. 10.1016/S0959-4388(96)80121-8.View ArticlePubMedGoogle Scholar
- Isaacson JS, Hille B: GABAB-mediated presynaptic inhibition of excitatory transmission and synaptic vesicle dynamics in cultured hippocampal neurons. Neuron. 1997, 18 (1): 143-152. 10.1016/S0896-6273(01)80053-2.View ArticlePubMedGoogle Scholar
- Ariano MA, Sibley DR: Dopamine receptor distribution in the rat CNS: elucidation using anti-peptide antisera directed against D1A and D3 subtypes. Brain Research. 1994, 649: 95-110. 10.1016/0006-8993(94)91052-9.View ArticlePubMedGoogle Scholar
- Ariano MA, Fisher RS, Smyk-Randall E, Sibley DR, Levine MS: D2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera. Brain Research. 1993, 609: 71-80. 10.1016/0006-8993(93)90857-J.View ArticlePubMedGoogle Scholar
- Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KKL, Bolam JP, Ince E, Yi H, Levey AI: Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. Journal of Neuroscience. 1995, 15 (7 PT 2): 5222-5237.PubMedGoogle Scholar
- Farooqui SM, Brock JW, Hamdi A, Prasad C: Antibodies against synthetic peptides predicted from the nucleotide sequence of D2 receptor recognize native dopamine receptor protein in rat striatum. Journal of Neurochemistry. 1991, 57: 1363-1369.View ArticlePubMedGoogle Scholar
- Marty A, Llano I: Excitatory effects of GABA in established brain networks. Trends Neurosci. 2005, 28 (6): 284-289. 10.1016/j.tins.2005.04.003.View ArticlePubMedGoogle Scholar
- Onn SP, Grace AA: Alterations in electrophysiological activity and dye coupling of striatal spiny and aspiny neurons in dopamine-denervated rat striatum recorded in vivo. Synapse. 1999, 33 (1): 1-15. 10.1002/(SICI)1098-2396(199907)33:1<1::AID-SYN1>3.0.CO;2-G.View ArticlePubMedGoogle Scholar
- Auger C, Kondo S, Marty A: Multivesicular release at single functional synaptic sites in cerebellar stellate and basket cells. J Neurosci. 1998, 18 (12): 4532-4547.PubMedGoogle Scholar
- Mizuno T, Schmauss C, Rayport S: Distinct roles of presynaptic dopamine receptors in the differential modulation of the intrinsic synapses of striatal medium-spiny neurons. In submission.Google Scholar
- Huang ZJ: Subcellular organization of GABAergic synapses: role of ankyrins and L1 cell adhesion molecules. Nat Neurosci. 2006, 9 (2): 163-166. 10.1038/nn1638.View ArticlePubMedGoogle Scholar
- Stelzer A, Kay AR, Wong RK: GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors. Science. 1988, 241 (4863): 339-341.View ArticlePubMedGoogle Scholar
- Pouzat C, Marty A: Somatic recording of GABAergic autoreceptor current in cerebellar stellate and basket cells. J Neurosci. 1999, 19 (5): 1675-1690.PubMedGoogle Scholar
- Waldvogel HJ, Billinton A, White JH, Emson PC, Faull RL: Comparative cellular distribution of GABAA and GABAB receptors in the human basal ganglia: immunohistochemical colocalization of the α1 subunit of the GABAA receptor, and the GABABR1 and GABABR2 receptor subunits. J Comp Neurol. 2004, 470 (4): 339-356. 10.1002/cne.20005.View ArticlePubMedGoogle Scholar
- Zhang W, Klimek V, Farley JT, Zhu MY, Ordway GA: α2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine. J Pharmacol Exp Ther. 1999, 289 (3): 1286-1292.PubMedGoogle Scholar
- Gazi L, Nickolls SA, Strange PG: Functional coupling of the human dopamine D2 receptor with Gαi1, Gαi2, Gαi3 and Gαo G proteins: evidence for agonist regulation of G protein selectivity. Br J Pharmacol. 2003, 138 (5): 775-786. 10.1038/sj.bjp.0705116.PubMed CentralView ArticlePubMedGoogle Scholar
- Mottola DM, Laiter S, Watts VJ, Tropsha A, Wyrick SD, Nichols DE, Mailman RB: Conformational analysis of D1 dopamine receptor agonists: Pharmacophore assessment and receptor mapping. Journal of Medicinal Chemistry. 1996, 39 (1): 285-296. 10.1021/jm9502100.View ArticlePubMedGoogle Scholar
- Wiens BL, Nelson CS, Neve KA: Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist- specific active conformations. Mol Pharmacol. 1998, 54 (2): 435-444.PubMedGoogle Scholar
- Gay EA, Urban JD, Nichols DE, Oxford GS, Mailman RB: Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states. Mol Pharmacol. 2004, 66 (1): 97-105. 10.1124/mol.66.1.97.View ArticlePubMedGoogle Scholar
- Carter-Russell HR, Song WJ, Surmeier DJ: Coordinated expression of dopamine receptors (D1-D5) in single neostriatal neurons. Society for Neuroscience Abstracts. 1995, 21: 1425.Google Scholar
- Yasumoto S, Tanaka E, Hattori G, Maeda H, Higashi H: Direct and indirect actions of dopamine on the membrane potential in medium spiny neurons of the mouse neostriatum. J Neurophysiol. 2002, 87 (3): 1234-1243.PubMedGoogle Scholar
- Flores-Hernandez J, Hernandez S, Snyder GL, Yan Z, Fienberg AA, Moss SJ, Greengard P, Surmeier DJ: D1 dopamine receptor activation reduces GABAA receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J Neurophysiol. 2000, 83 (5): 2996-3004.PubMedGoogle Scholar
- Fisher RS, Levine MS, Sibley DR, Ariano MA: D2 dopamine receptor protein location: Golgi impregnation-gold toned and ultrastructural analysis of the rat neostriatum. Journal of Neuroscience Research. 1994, 38 (5): 551-564. 10.1002/jnr.490380508.View ArticlePubMedGoogle Scholar
- Sesack SR, Aoki C, Pickel VM: Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. Journal of Neuroscience. 1994, 14: 88-106.PubMedGoogle Scholar
- Yung KKL, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI: Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 1995, 65 (3): 709-730. 10.1016/0306-4522(94)00536-E.View ArticlePubMedGoogle Scholar
- Delle Donne KT, Sesack SR, Pickel VM: Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Research. 1997, 746 (1-2): 239-255. 10.1016/S0006-8993(96)01226-7.View ArticlePubMedGoogle Scholar
- Yung KK, Bolam JP: Localization of dopamine D1 and D2 receptors in the rat neostriatum: Synaptic interaction with glutamate- and GABA-containing axonal terminals. Synapse. 2000, 38 (4): 413-420. 10.1002/1098-2396(20001215)38:4<413::AID-SYN6>3.0.CO;2-V.View ArticlePubMedGoogle Scholar
- Wang H, Pickel VM: Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol. 2002, 442 (4): 392-404. 10.1002/cne.10086.View ArticlePubMedGoogle Scholar
- Benoit-Marand M, Borrelli E, Gonon F: Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci. 2001, 21 (23): 9134-9141.PubMedGoogle Scholar
- Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D: Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron. 2004, 42 (4): 653-663. 10.1016/S0896-6273(04)00265-X.View ArticlePubMedGoogle Scholar
- Delgado A, Sierra A, Querejeta E, Valdiosera RF, Aceves J: Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Neuroscience. 2000, 95 (4): 1043–1048.PubMedGoogle Scholar
- Masson J, Lee JY, Javitch JA, Rayport S: Presynaptic targeting of D2 dopamine receptors in nucleus accumbens neurons in vitro. Soc Neurosci Abstr. 1999, 25: 954.Google Scholar
- Banerjee P, Joo JB, Buse JT, Dawson G: Differential solubilization of lipids along with membrane proteins by different classes of detergents. Chem Phys Lipids. 1995, 77 (1): 65-78. 10.1016/0009-3084(95)02455-R.View ArticlePubMedGoogle Scholar
- Seutin V, Johnson SW: Recent advances in the pharmacology of quaternary salts of bicuculline. Trends Pharmacol Sci. 1999, 20 (7): 268-270. 10.1016/S0165-6147(99)01334-6.View ArticlePubMedGoogle Scholar
- Bookman RJ: PulseControl 5.0. 1996, http://chroma.med.miami.edu/capGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.